95 related articles for article (PubMed ID: 10769675)
1. Expression of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in primary lung carcinomas.
Suzuki S; Suzuki T; Tsubochi H; Koike K; Tateno H; Krozowski ZS; Sasano H
Anticancer Res; 2000; 20(1A):323-8. PubMed ID: 10769675
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
3. 11 beta-hydroxysteroid dehydrogenase type II in human colon: a new marker of fetal development and differentiation in neoplasms.
Takahashi K; Sasano H; Fukushima K; Hirasawa G; Miura H; Sasaki I; Matsuno S; Krozowski ZS; Nagura H
Anticancer Res; 1998; 18(5A):3381-8. PubMed ID: 9858912
[TBL] [Abstract][Full Text] [Related]
4. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
5. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.
Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M
Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683
[TBL] [Abstract][Full Text] [Related]
6. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
[TBL] [Abstract][Full Text] [Related]
7. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
11. Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study.
Małusecka E; Zborek A; Krzyzowska-Gruca S; Krawczyk Z
Anticancer Res; 2001; 21(2A):1015-21. PubMed ID: 11396134
[TBL] [Abstract][Full Text] [Related]
12. CD34-positive stromal cells in primary lung carcinomas.
Nakayama H; Enzan H; Yamamoto M; Miyazaki E; Hidaka C; Okumichi T; Okumichi A; Kajihara H
Oncol Rep; 2003; 10(5):1313-6. PubMed ID: 12883699
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
15. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation.
Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlöf AK; Björnstedt M
Histopathology; 2009 Sep; 55(3):313-20. PubMed ID: 19723146
[TBL] [Abstract][Full Text] [Related]
17. Expression of hnRNP B1 in four major histological types of lung cancers.
Hamasaki M; Kamma H; Wu W; Kaneko S; Fujiwara M; Satoh H; Haraoka S; Kikuchi M; Shirakusa T
Anticancer Res; 2001; 21(2A):979-84. PubMed ID: 11396191
[TBL] [Abstract][Full Text] [Related]
18. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
19. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in lung carcinomas among three Latin American countries.
Castillo A; Aguayo F; Koriyama C; Shuyama K; Akiba S; Herrera-Goepfert R; Carrascal E; Klinge G; Sánchez J; Eizuru Y
Oncol Rep; 2006 Apr; 15(4):883-8. PubMed ID: 16525675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]